Electrophysiological evidence that noradrenergic afferents selectively facilitate the activity of supraoptic vasopressin neurons.
The functional role of the ascending projection from A1 noradrenergic neurons of the caudal ventrolateral medulla to the supraoptic nucleus of the hypothalamus was investigated by examining the effects of electrical stimulation of the A1 region on the activity of supraoptic neurons deemed to be vasopressinergic or oxytocinergic on the basis of basal firing patterns and responsivity to baroreceptor activation. A1 stimulation enhanced the activity of all putative vasopressin-secreting supraoptic neurons tested. This effect appeared to be selective in that no putative oxytocin-secreting neurons were excited by A1 stimulation. Destruction of the supraoptic noradrenergic terminal plexus by local application of the neurotoxin 6-hydroxydopamine abolished the facilitatory effects of A1 stimulation but did not noticeably alter basal activity patterns, nor the influence of baroreceptor inhibitory pathways. These findings suggest a facilitatory role for noradrenergic afferents in regulating the activity of neurohypophysially-projecting vasopressin neurons of the supraoptic nucleus.
D000344:Afferent Pathways / Q000502:physiology; D000818:Animals; D001794:Blood Pressure; D008297:Male; D008526:Medulla Oblongata / Q000502:physiology*; D008856:Microscopy, Fluorescence; D009474:Neurons / Q000502:physiology; D009638:Norepinephrine / Q000502:physiology*; D010121:Oxytocin / Q000378:metabolism; D011311:Pressoreceptors / Q000502:physiology; D051381:Rats; D011919:Rats, Inbred Strains; D013495:Supraoptic Nucleus / Q000502:physiology*; D009435:Synaptic Transmission; D014667:Vasopressins / Q000378:metabolism*
D014667:Vasopressins; D010121:Oxytocin; D009638:Norepinephrine